Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia

International Journal of Antimicrobial Agents

Volumn 31, Issue 1, 2008, Pages 3-11

  Stralin K ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aetiology; Antibiotics; Community acquired pneumonia; Diagnostic tests; PCR; Urinary antigen test

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; ERYTHROMYCIN; FLUCLOXACILLIN; GENTAMICIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIBODY TITER; BACTERIUM CULTURE; BLOOD CULTURE; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; GRAM STAINING; HUMAN; LEGIONELLA; LUNG INFILTRATE; LUNG LAVAGE; MONOTHERAPY; MYCOPLASMA PNEUMONIAE; NOSE SECRETION; PLEURA FLUID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIODIAGNOSIS; RELIABILITY; SHORT SURVEY; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; BACTERIA; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; PNEUMONIA, BACTERIAL;

EID: 36849012587     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.06.037     Document Type: Short Survey

References (82)

1. Jokinen C., Heiskanen L., Juvonen H., et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 137 (1993) 977-988
2. Fine M.J., Smith M.A., Carson C.A., et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA 275 (1996) 134-141
3. Niederman M.S. Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms. Clin Infect Dis 42 Suppl. 2 (2006) S72-S81
4. Mandell L.A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 Suppl. 2 (2007) S27-S72
5. Mandell L.A., Marrie T.J., Grossman R.F., Chow A.W., Hyland R.H., and The Canadian Community-Acquired Pneumonia Working Group. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 31 (2000) 383-421
6. Woodhead M., Blasi F., Ewig S., et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 26 (2005) 1138-1180
7. Macfarlane J, Boswell T, Douglas G, et al. BTS guidelines for the management of community-acquired pneumonia in adults - 2004 update. URL: http://www.brit-thoracic.org.uk/c2/uploads/MACAPrevisedApr04.pdf, 2004.
8. Hedlund J., Strålin K., Örtqvist A., Holmberg H., and Community-Acquired Pneumonia Working Group of the Swedish Society of Infectious Diseases. Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults. Scand J Infect Dis 37 (2005) 791-805
9. Schouten J.A., Prins J.M., Bonten M.J., et al. Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia. Neth J Med 63 (2005) 323-335
10. Lieberman D., Schlaeffer F., Boldur I., et al. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax 51 (1996) 179-184
11. Ruiz M., Ewig S., Marcos M.A., et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 160 (1999) 397-405
12. van der Eerden M.M., Vlaspolder F., de Graaff C.S., et al. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study. Thorax 60 (2005) 672-678
13. Lidman C., Burman L.G., Lagergren A., and Ortqvist A. Limited value of routine microbiological diagnostics in patients hospitalized for community-acquired pneumonia. Scand J Infect Dis 34 (2002) 873-879
14. Bronzwaer S.L., Cars O., Buchholz U., et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8 (2002) 278-282
15. Paterson D.L. "Collateral damage" from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 38 Suppl. 4 (2004) S341-S345
16. Peterson L.R. Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?. Clin Infect Dis 42 (2006) 224-233
17. Falagas M.E., Siempos I.I., Bliziotis I.A., and Panos G.Z. Impact of initial discordant treatment with beta-lactam antibiotics on clinical outcomes in adults with pneumococcal pneumonia: a systematic review. Mayo Clin Proc 81 (2006) 1567-1574
18. Yu V.L., Chiou C.C., Feldman C., et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 37 (2003) 230-237
19. Mills G.D., Oehley M.R., and Arrol B. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ 330 (2005) 456
20. Shefet D., Robenshtok E., Paul M., and Leibovici L. Empirical atypical coverage for inpatients with community-acquired pneumonia: systematic review of randomized controlled trials. Arch Intern Med 165 (2005) 1992-2000
21. Fang G.D., Fine M., Orloff J., et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine (Baltimore) 69 (1990) 307-316
22. Holmberg H., Bodin L., Jonsson I., and Krook A. Rapid aetiological diagnosis of pneumonia based on routine laboratory features. Scand J Infect Dis 22 (1990) 537-545
23. Farr B.M., Kaiser D.L., Harrison B.D., and Connolly C.K. Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features: British Thoracic Society Pneumonia Research Subcommittee. Thorax 44 (1989) 1031-1035
24. Woodhead M.A., and Macfarlane J.T. Comparative clinical and laboratory features of Legionella with pneumococcal and mycoplasma pneumonias. Br J Dis Chest 81 (1987) 133-139
25. Mulazimoglu L., and Yu V.L. Can Legionnaires disease be diagnosed by clinical criteria? A critical review. Chest 120 (2001) 1049-1053
26. Strålin K., and Holmberg H. Usefulness of the Streptococcus pneumoniae urinary antigen test in the treatment of community-acquired pneumonia. Clin Infect Dis 41 (2005) 1209-1210
27. Marston B.J., Plouffe J.F., File Jr. T.M., et al., The Community-Based Pneumonia Incidence Study Group. Incidence of community-acquired pneumonia requiring hospitalisation. Results of a population-based active surveillance study in Ohio. Arch Intern Med 157 (1997) 1709-1718
28. Strålin K., Törnqvist E., Kaltoft M.S., Olcén P., and Holmberg H. Etiologic diagnosis of adult bacterial pneumonia by culture and PCR applied to respiratory tract samples. J Clin Microbiol 44 (2006) 643-645
29. Scott J.A., and Hall A.J. The value and complications of percutaneous transthoracic lung aspiration for the etiologic diagnosis of community-acquired pneumonia. Chest 116 (1999) 1716-1732
30. Meehan T.P., Fine M.J., Krumholz H.M., et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 278 (1997) 2080-2084
31. Rome L., Murali G., and Lippmann M. Nonresolving pneumonia and mimics of pneumonia. Med Clin North Am 85 (2001) 1511-30, xi
32. Murray P.R., and Washington J.A. Microscopic and baceriologic analysis of expectorated sputum. Mayo Clin Proc 50 (1975) 339-344
33. Kalin M., Lindberg A.A., and Tunevall G. Etiological diagnosis of bacterial pneumonia by gram stain and quantitative culture of expectorates: leukocytes or alveolar macrophages as indicators of sample representativity. Scand J Infect Dis 15 (1983) 153-160
34. Kalin M., and Lindberg A.A. Diagnosis of pneumococcal pneumonia: a comparison between microscopic examination of expectorate, antigen detection and cultural procedures. Scand J Infect Dis 15 (1983) 247-255
35. Pirtle J.K., Monroe P.W., Smalley T.K., Mohr J.A., and Rhoades E.R. Diagnostic and therapeutic advantages of serial quantitative cultures of fresh sputum in acute bacterial pneumonia. Am Rev Respir Dis 100 (1969) 831-838
36. Gillet Y., Issartel B., Vanhems P., et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359 (2002) 753-759
37. Örtqvist A. Commentary to 'Community-acquired pneumonia due to Escherichia coli' by Marrie TJ et al. Clin Microbiol Infect 4 (1998) 724-725
38. Murdoch D.R. Diagnosis of Legionella infection. Clin Infect Dis 36 (2003) 64-69
39. Fishman J.A., Roth R.S., Zanzot E., Enos E.J., and Ferraro M.J. Use of induced sputum specimens for microbiologic diagnosis of infections due to organisms other than Pneumocystis carinii. J Clin Microbiol 32 (1994) 131-134
40. Cook D.J., Fitzgerald J.M., Guyatt G.H., and Walter S. Evaluation of the protected brush catheter and bronchoalveolar lavage in the diagnosis of nosocomial pneumonia. J Intensive Care Med 6 (1991) 196-205
41. Kirkpatrick M.B., and Bass Jr. J.B. Quantitative bacterial cultures of bronchoalveolar lavage fluids and protected brush catheter specimens from normal subjects. Am Rev Respir Dis 139 (1989) 546-548
42. Menendez R., Cordoba J., de La Cuadra P., et al. Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia. Am J Respir Crit Care Med 159 (1999) 1868-1873
43. Hedlund J., Örtqvist A., and Kalin M. Nasopharyngeal culture in the pneumonia diagnosis. Infection 18 (1990) 283-285
44. Strålin K. Diagnostic methods for bacterial etiology in adult community-acquired pneumonia (PhD thesis). Linköping: Linköping University, 2005.
45. Fransen H., and Wolontis S. Infections with viruses, Mycoplasma pneumoniae and bacteria in acute respiratory illness. A study of hospitalized patients, patients treated at home, and healthy subjects. Scand J Infect Dis 1 (1969) 31-37
46. Holmberg H. Aetiology of community-acquired pneumonia in hospital treated patients. Scand J Infect Dis 19 (1987) 491-501
47. Gunnarsson R.K., Holm S.E., and Söderström M. The prevalence of potential pathogenic bacteria in nasopharyngeal samples from healthy children and adults. Scand J Prim Health Care 16 (1998) 13-17
48. Cooper G.M., Jones J.J., Arbique J.C., Flowerdew G.J., and Forward K.R. Intra and inter technologist variability in the quality assessment of respiratory tract specimens. Diagn Microbiol Infect Dis 37 (2000) 231-235
49. Fine M.J., Orloff J.J., Rihs J.D., et al. Evaluation of housestaff physicians' preparation and interpretation of sputum Gram stains for community-acquired pneumonia. J Gen Intern Med 6 (1991) 189-198
50. Reed W.W., Byrd G.S., Gates Jr. R.H., Howard R.S., and Weaver M.J. Sputum gram's stain in community-acquired pneumococcal pneumonia A meta-analysis. West J Med 165 (1996) 197-204
51. Musher D.M., Montoya R., and Wanahita A. Diagnostic value of microscopic examination of gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 39 (2004) 165-169
52. Gleckman R., DeVita J., Hibert D., Pelletier C., and Martin R. Sputum gram stain assessment in community-acquired bacteremic pneumonia. J Clin Microbiol 26 (1988) 846-849
53. Boerner D.F., and Zwadyk P. The value of the sputum gram's stain in community-acquired pneumonia. JAMA 247 (1982) 642-645
54. Roson B., Carratala J., Verdaguer R., Dorca J., Manresa F., and Gudiol F. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis 31 (2000) 869-874
55. Dominguez J., Gali N., Blanco S., et al. Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples. Chest 119 (2001) 243-249
56. Smith M.D., Derrington P., Evans R., et al. Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation. J Clin Microbiol 41 (2003) 2810-2813
57. Strålin K., Kaltoft M.S., Konradsen H.B., Olcén P., and Holmberg H. Comparison of two urinary antigen tests for establishment of pneumococcal etiology of adult community-acquired pneumonia. J Clin Microbiol 42 (2004) 3620-3625
58. Marcos M.A., Jimenez de Anta M.T., de la Bellacasa J.P., et al. Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults. Eur Respir J 21 (2003) 209-214
59. Palmu A., Kaijalainen T., Leinonen M., Mäkelä P.H., and Kilpi T. Nasopharyngeal carriage and pneumococcal urine antigen test in healthy elderly subjects. 4th International Symposium on Pneumococci and Pneumococcal Disease. Helsinki, Finland; 2004 (2004)
60. Murdoch D.R., Laing R.T., and Cook J.M. The NOW S. pneumoniae urinary antigen test positivity rate 6 weeks after pneumonia onset and among patients with COPD. Clin Infect Dis 37 (2003) 153-154
61. Guchev I.A., Yu V.L., Sinopalnikov A., Klochkov O.I., Kozlov R.S., and Stratchounski L.S. Management of nonsevere pneumonia in military trainees with the urinary antigen test for Streptococcus pneumoniae: an innovative approach to targeted therapy. Clin Infect Dis 40 (2005) 1608-1616
62. Lettinga K.D., Verbon A., Weverling G.J., et al. Legionnaires' disease at a Dutch flower show: prognostic factors and impact of therapy. Emerg Infect Dis 8 (2002) 1448-1454
63. Murdoch D.R. Molecular genetic methods in the diagnosis of lower respiratory tract infections. APMIS 112 (2004) 713-727
64. Gnarpe J., Lundback A., Sundelof B., and Gnarpe H. Prevalence of Mycoplasma pneumoniae in subjectively healthy individuals. Scand J Infect Dis 24 (1992) 161-164
65. Hyman C.L., Roblin P.M., Gaydos C.A., Quinn T.C., Schachter J., and Hammerschlag M.R. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis 20 (1995) 1174-1178
66. Foy H.M., Grayston J.T., Kenny G.E., Alexander E.R., and McMahan R. Epidemiology of Mycoplasma pneumoniae infection in families. JAMA 197 (1966) 859-866
67. Hammerschlag M.R., Chirgwin K., Roblin P.M., et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 14 (1992) 178-182
68. Strålin K., Korsgaard J., and Olcén P. Evaluation of a multiplex PCR for bacterial pathogens applied to bronchoalveolar lavage. Eur Respir J 28 (2006) 568-575
69. Örtqvist A., Kalin M., Lejdeborn L., and Lundberg B. Diagnostic fiberoptic bronchoscopy and protected brush culture in patients with community-acquired pneumonia. Chest 97 (1990) 576-582
70. Peters R.P., van Agtmael M.A., Danner S.A., Savelkoul P.H., and Vandenbroucke-Grauls C.M. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 4 (2004) 751-760
71. Petric M., Comanor L., and Petti C.A. Role of the laboratory in diagnosis of influenza during seasonal epidemics and potential pandemics. J Infect Dis 194 Suppl. 2 (2006) S98-S110
72. Hurt A.C., Alexander R., Hibbert J., Deed N., and Barr I.G. Performance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol 39 (2007) 132-135
73. Cunha B.A. Influenza: historical aspects of epidemics and pandemics. Infect Dis Clin North Am 18 (2004) 141-155
74. Falsey A.R., Murata Y., and Walsh E.E. Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch Intern Med 167 (2007) 354-360
75. Oosterheert J.J., van Loon A.M., Schuurman R., et al. Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection. Clin Infect Dis 41 (2005) 1438-1444
76. Daxboeck F., Krause R., and Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect 9 (2003) 263-273
77. Dowell S.F., Peeling R.W., Boman J., et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 33 (2001) 492-503
78. Ewig S., Bauer T., Hasper E., Marklein G., Kubini R., and Luderitz B. Value of routine microbial investigation in community-acquired pneumonia treated in a tertiary care center. Respiration 63 (1996) 164-169
79. Rello J., Bodi M., Mariscal D., et al. Microbiological testing and outcome of patients with severe community-acquired pneumonia. Chest 123 (2003) 174-180
80. Bartlett J.G. Community-acquired pneumonia. N Engl J Med 334 (1996) 863
81. Bauer T.T., Welte T., Ernen C., et al. Cost analyses of community-acquired pneumonia from the hospital perspective. Chest 128 (2005) 2238-2246
82. Wheeler J., Murphy O.M., Freeman R., Kearns A.M., Steward M., and Lee M.J. PCR can add to detection of pneumococcal disease in pneumonic patients receiving antibiotics at admission. J Clin Microbiol 38 (2000) 3907